Cognyte Software (NASDAQ:CGNT) Shares Pass Above Two Hundred Day Moving Average of $6.31

Cognyte Software Ltd. (NASDAQ:CGNT) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.31 and traded as high as $7.01. Cognyte Software shares last traded at $6.91, with a volume of 191,281 shares traded.

Analysts Set New Price Targets

A number of analysts have commented on CGNT shares. Wedbush increased their price objective on shares of Cognyte Software from $5.00 to $8.00 and gave the company a “neutral” rating in a report on Thursday, April 11th. StockNews.com upgraded Cognyte Software from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, April 10th. Evercore ISI upped their target price on Cognyte Software from $5.00 to $7.50 and gave the company an “in-line” rating in a report on Wednesday, April 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cognyte Software in a report on Tuesday, April 9th.

Cognyte Software Trading Up 0.1 %

The firm has a market cap of $490.75 million, a price-to-earnings ratio of -30.04 and a beta of 1.68. The stock’s fifty day moving average price is $7.44 and its 200-day moving average price is $6.31.

Institutional Investors Weigh In On Cognyte Software

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CGNT. Tower Research Capital LLC TRC acquired a new stake in shares of Cognyte Software during the 4th quarter worth about $37,000. Quantbot Technologies LP purchased a new position in Cognyte Software during the third quarter worth about $57,000. Russell Investments Group Ltd. increased its position in shares of Cognyte Software by 8,624.3% during the fourth quarter. Russell Investments Group Ltd. now owns 20,066 shares of the medical device company’s stock valued at $129,000 after acquiring an additional 19,836 shares during the last quarter. Mackenzie Financial Corp raised its stake in shares of Cognyte Software by 56.1% in the 4th quarter. Mackenzie Financial Corp now owns 21,986 shares of the medical device company’s stock valued at $141,000 after acquiring an additional 7,899 shares during the period. Finally, Quadrature Capital Ltd acquired a new position in shares of Cognyte Software in the 4th quarter worth approximately $144,000. Institutional investors and hedge funds own 72.92% of the company’s stock.

Cognyte Software Company Profile

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.